WHY?
As an Alzheimer's patient and someone who advocates for patients and conducts research, I firmly believe that NeuralCIM is a therapy worth considering for individuals in the early to mid stages of the disease.
Like any emerging product, there are individuals looking to exploit, and possibly take advantage of, this opportunity for financial gain. The most reliable information can be found from current users of NeuralCIM, reputable scientific journals, and thoroughly vetted service providers.
NeuralCIM.info serves as a community portal aimed at sharing information freely. There is no cost to use NeuralCIM.info.
I commit to never selling advertising or accepting donations from anyone directly involved with NeuralCIM. However, I welcome donations from the community to help cover the time and resources needed to develop and maintain the website. Additionally, NeuralCIM merchandise will be available for purchase.
NeuralCIM.info Is Not:
-
A medical provider, and no medical advice is offered
-
Associated with the manufacturer of NeuralCIM
-
Associated with any travel agency, or other group coordinating trips to Cuba
HOW?
Community members submit information and questions.
neuralCIM.info posts the submissions to the site blog
Community members read and respond to the blog posts
Active participation and constructive conversation is the key to the success of the portal.
SUBMISSIONS & QUESTIONS
About Greg
I am 68 years old. In September 2025, I was diagnosed with early-stage Alzheimer's disease. For eight months, I took Lecanemab infusions at Duke Neurology. Due to side effects, my doctors pulled me off Lecanemab.
Like so many other Alzheimer's patients, I am desperately seeking a treatment that will slow down the disease progression and maybe restore some cognitive function.
